This observational study is looking at new ways to detect and monitor glaucoma, a condition that can cause vision loss. Researchers are developing and testing advanced imaging tools, specifically a high-resolution OCT (Optical Coherence Tomography) and OCT angiography prototype. These tools aim to improve how we see the structure and blood flow in the eye. The study will measure areas of retinal non-perfusion (areas without blood flow) and vessel density, and compare simulated visual field results from these new technologies to actual visual field tests. You may be eligible if you are between 40 and 85 years old and have no history of retinal problems or glaucoma, with normal visual field tests and eye pressure. The current status of this study is unclear.

Study design

This is an observational study with a planned enrollment of 160 participants. It is not a treatment study, but rather focuses on improving diagnostic tools.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary measurements will be taken at 5 years, suggesting a long-term follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.